Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. 2019
  2. Published

    Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients

    Khurana, Mark Poulsen, Lodding, I. P., Mocroft, A., Sørensen, Søren Schwartz, Perch, Michael, Rasmussen, A., Gustafsson, Finn & Lundgren, Jens, 2019, In: Open Forum Infectious Diseases. 6, 6, 10 p., ofz215.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators

    Bansi-Matharu, L., Loria, G. R., Cole, S. R., Mugerwa, H., Vecino, I., Lundgren, Jens, Pulik, P., Smith, C., Phillips, A. N. & INSIGHT START Study Group, I. S. S. G., 2019, In: AIDS. 33, 8, p. 1385-1390 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

    Phillips, A. N., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D., Wensing, A., Lundgren, J. D., De Luca, A., Pillay, D., Mellors, J., Cambiano, V., Bansi-Matharu, L., Nakagawa, F., Kalua, T., Jahn, A., Apollo, T., Mugurungi, O., Clayden, P., Gupta, R. K., Barnabas, R. & 4 others, Revill, P., Cohn, J., Bertagnolio, S. & Calmy, A., 2019, In: The Lancet HIV. 6, 2, p. e116-e127

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Serious clinical events in HIV-positive persons with chronic kidney disease

    Ryom, L., Lundgren, Jens, Law, M., Kirk, Ole, El-Sadr, W., Bonnet, F., Weber, R., Fontas, E., Monforte, A. D., Phillips, A., Reiss, P., de Wit, S., Hatleberg, C. I., Sabin, C., Mocroft, A. & D:A:D Study Group, D. S. G., 2019, In: AIDS. 33, 14, p. 2173-2188 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis

    INSIGHT SMART, I. S., 2019, In: The Journal of Infectious Diseases. 219, 2, p. 254-263

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

    Neesgaard, B., Pelchen-Matthews, A., Ryom, L., Florence, E., Peters, L., Roen, A., Svedhem, V., Clarke, A., Benfield, T., Mitsura, V., Moreno, S., Beniowski, M., Begovac, J., Matulionyte, R., Trofimova, T., Elbirt, D., Kundro, M., Vullo, V., Behrens, G., Staub, T. & 5 others, Ragone, L., Vannappagari, V., Lundgren, Jens, Mocroft, A. & EuroSIDA Study, E. S., 2019, In: AIDS. 33, 13, p. 2013-2024 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

    Andersen, M. A., Moser, Claus Ernst, Lundgren, Jens & Niemann, Carsten, Mar 2019, In: Leukemia. 33, 3, p. 662-670 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

    Eurosida Study Group, E. S. G., Apr 2019, In: HIV Medicine. 20, 4, p. 264-273 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

    Ilett, E. E., Helleberg, M., Reekie, J., Murray, D. D., Wulff, S. M., Khurana, Mark Poulsen, Mocroft, A., Daugaard, G., Perch, Michael, Rasmussen, A., Sørensen, Søren Schwartz, Gustafsson, Finn, Frimodt-møller, N., Sengeløv, Henrik & Lundgren, Jens, 1 Apr 2019, In: Open Forum Infectious Diseases. 6, 4, 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial

    INSIGHT START Study Group, I. S. S. G., 1 May 2019, In: Journal of acquired immune deficiency syndromes (1999). 81, 1, p. 10-17

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13961